NEW
Stock Screener with Intrinsic Value
Amgen Inc. (AMGN)
Last Price$288.91.2%
Market Cap$155.1B
WACC
5.9%
Cost of Equity
7.8%
Cost of Debt
1.2%
Debt to Equity
38.9%
Beta
0.7
Stock quality
5/10
Good
AMGN WACC
Crunching data... Almost there!
Best stock ideas on the market right now
With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.
AMGN Cost of Equity
Crunching data... Almost there!
AMGN vs Peer Set: Discount Rate Comparison
WACC
Cost of Equity
General
Discount rate
financials
Company name
Revenue growth
EPS growth
Net Income margin
Amgen Inc.AMGN
5.9%
7.1%
3.1%
23.8%
Median Peer Set
6.7%
(0.6%)
(15.9%)
15.4%
Eli Lilly and CompanyLLY
7.5%
19.6%
(15.9%)
15.4%
Johnson & JohnsonJNJ
7.1%
6.5%
102.3%
41.3%
Novartis AGNVS
6.9%
(10.0%)
124.1%
31.8%
Merck & Co., Inc.MRK
6.8%
1.4%
(97.6%)
0.6%
Gilead Sciences, Inc.GILD
6.7%
(0.6%)
24.0%
20.9%
AbbVie Inc.ABBV
6.5%
(6.4%)
(58.9%)
9.0%
Pfizer Inc.PFE
5.7%
(41.7%)
(93.2%)
3.6%
Bristol-Myers Squibb CompanyBMY
5.7%
(2.5%)
30.6%
17.8%
SanofiSNY
negative
4.1%
(33.9%)
11.7%
Explore more intrinsic value tools hub for AMGN
Peter Lynch Fair Value
Margin of safety
Reverse DCF
Relative Value
DCF value calculator
Ben Graham Fair Value
Intrinsic Value
Peter Lynch charts
Earnings growth model
Earnings Power Value
Loved by
investors
worldwide
investors
worldwide
10K+
Investors
use our platform
#1
Top value investing hub
with all necessary tools
1K+
Experienced investors
in our community
4.9
Average rating across
all rating platforms
FAQ
What is Amgen Inc.'s discount rate as of Feb 03, 2025?
As of Feb 03, 2025, Amgen Inc.'s discount rate is 5.91%. This rate is determined based on the weighted average cost of capital (WACC) and the cost of equity, factoring in Amgen Inc.'s capital structure and risk profile.
What is Amgen Inc.'s weighted average cost of capital (WACC)?
Amgen Inc.'s WACC as of Feb 03, 2025, is 5.91%. This value is calculated by blending the cost of debt and cost of equity, reflecting the company’s overall cost of financing its operations.
What is Amgen Inc.'s cost of equity?
Amgen Inc.'s cost of equity is 7.8%, as of Feb 03, 2025. This is the return that shareholders expect based on the stock's risk level and market conditions, used to calculate the discount rate for valuing future cash flows.